Beckman Coulter Launches the UniCel® DxI 600 at EuroMedLab 2007

Beckman Coulter, Inc. has launched the next analyser in its series of in vitro diagnostic offerings, the UniCel® DxI 600 Access® Immunoassay System, an innovative immunochemistry instrument designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.

The UniCel® DxI 600
The UniCel® DxI 600
The DxI® 600 is ideal for laboratories processing up to 200 tests per hour and releases the primary tube in less than five minutes. Its features include refrigerated storage for 50-reagent packs and on-board aliquotting. “The DxI 600 makes it possible for laboratories to perform lower-volume assays in-house – immediately reducing outsourcing costs and improving laboratory efficiency,” said Richard Creager, corporate vice president, Immunoassay Business Center.
 
Built from the same proven technology used in the DxI 800, the DxI 600 can facilitate workstation consolidation and expand laboratory testing to include high - quality assays such as AccuTnI® Troponin I. In addition, it uses the same reagent pack as other analysers in the family, a feature important to integrated healthcare networks. “With the introduction of the DxI 600, these networks can streamline testing and optimise labour resources while allowing individual laboratories within the network to find the analyser that best meets their specific throughput requirements,” added Creager.
 
Healthcare networks can standardise inventory and lab testing methods across multiple locations, allowing for increased consistency in results, reduced errors and improved efficiency. The UniCel family of multi-platform systems is designed to be cross-functional, accommodating chemistry, immunoassay or haematology, and other automated components currently in development.
 
UniCel DxCi systems evolved from Beckman Coulter’s market-leading Access and Synchron® technologies, offering a broad test menu, accurate results and exceptional reliability. Each system is designed to help clinical laboratories consolidate workstations, reduce costs and optimise labour resources. The UniCel line also improves productivity by enabling healthcare networks to standardise inventory and lab testing methods across multiple locations, allowing for increased consistency in results, reduced errors and improved patient safety. For more information, visit http://www.beckmancoulter.com/Default.asp?bhfv=7
 

05.06.2007

More on the subject:More on companies:
Read all latest stories

Related articles

Photo

Blood poisoning

Exploring the importance and challenges of early sepsis diagnosis

On the occasion of this year's World Sepsis Day, we spoke with Elena Sukhacheva, Ph.D., director of medical and scientific affairs at Beckman Coulter, about the status quo and outlook on sepsis…

Photo

Hematology

Early sepsis indicator helps identifying patients at risk

The critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early…

Photo

Innovation

Hematology: Advancements and future trends

While the role of the laboratory in disease diagnosis and management has expanded in recent years, causing an overwhelming rise in testing demands, the availability of skilled technologists and…

Related products

Beckman Coulter – Access 25(OH) Vitamin D Total

Immunoassays

Beckman Coulter – Access 25(OH) Vitamin D Total

Beckman Coulter, Inc.
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter, Inc.
Beckman Coulter – Access Active B12

Immunoassays

Beckman Coulter – Access Active B12

Beckman Coulter, Inc.
Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter, Inc.
Beckman Coulter – Anti-Mullerian Hormone (AMH)

Immunochemistry

Beckman Coulter – Anti-Mullerian Hormone (AMH)

Beckman Coulter, Inc.